Fulgent Genetics, Inc. | Business Contracts

Commercial Lease Addendum (II) by and between Fulgent Therapeutics LLC and E&E Plaza LLC (Filed With SEC on January 12, 2023)

Agreement and Plan of Merger, by and among Fulgent Genetics, FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc. and solely for purposes of Section 2.4, Section 5.5, Article VI,... (Filed With SEC on November 7, 2022)

Form of Notice of Restricted Stock Unit Award and Restricted Stock Unit Agreement under the Fulgent Pharma Holdings, Inc. 2022 Omnibus Incentive Plan (Filed With SEC on November 7, 2022)

Amended and Restated Non-Employee Director Compensation Policy, dated as of August 1, 2022 (Filed With SEC on November 7, 2022)

Fulgent Genetics, Inc. Incentive Compensation Recoupment Policy (Filed With SEC on March 29, 2022)

Amended and Restated Commercial Lease Agreement, dated May 6, 2016, by and between Store Master Funding IX, LLC and Cytometry Specialists, Inc (Filed With SEC on February 28, 2022)

Restructuring Agreement of Fujian Fujun Gene Biotech Co., Ltd (Filed With SEC on August 10, 2021)

Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 7, 2021)

Commercial Sublease Agreement, dated July 1st, 2020, between Medscan Laboratories Inc. and Fulgent Genetics, Inc.; Commercial Lease Agreement, dated June 17, 2020, by and between... (Filed With SEC on March 8, 2021)

Severance Agreement, dated March 8, 2021, by and among Fulgent Therapeutics LLC, Fulgent Genetics, Inc. and Jian Xie (Filed With SEC on March 8, 2021)

Employment Agreement, dated March 8, 2021, by and among Fulgent Therapeutics, LLC, Fulgent Genetics, Inc. and Jian Xie (Filed With SEC on March 8, 2021)

Commercial Lease Addendum, dated February 1, 2021, by and between E & E Plaza LLC and Fulgent Genetics, Inc (Filed With SEC on March 8, 2021)

Commercial Lease, dated January 11, 2021 by and between Ten-Voss Ltd., Medscan Laboratories, Inc. and Fulgent Genetics, Inc (Filed With SEC on March 8, 2021)

Equity Distribution Agreement, dated as of November 20, 2020, by and between Fulgent Genetics, Inc. and Piper Sandler & Co., BTIG, LLC, and Oppenheimer & Co. Inc (Filed With SEC on November 20, 2020)

Aircraft Purchase Agreement, dated August 18, 2020, by and between ServiceMaster Acceptance Corporation and the Company (Filed With SEC on November 9, 2020)

Agreement for Purchase and Sale of Property, dated July 23, 2020 (Filed With SEC on October 21, 2020)

Equity Distribution Agreement, dated as of September 24, 2020, by and between Fulgent Genetics, Inc. and Piper Sandler & Co (Filed With SEC on September 25, 2020)

Fulgent Genetics, Inc. Amended and Restated 2016 Omnibus Incentive Plan (Filed With SEC on September 18, 2020)

Amendment to Equity Distribution Agreement, dated as of August 4, 2020, by and between Fulgent Genetics, Inc. and Piper Sandler & Co (Filed With SEC on August 5, 2020)

Description of the registrants securities (Filed With SEC on March 13, 2020)

Purchase Agreement, dated as of November 13, 2019, by and between Fulgent Genetics, Inc. and Piper Jaffray & Co (Filed With SEC on November 14, 2019)

Equity Distribution Agreement, dated as of August 30, 2019, by and between Fulgent Genetics, Inc. and Piper Jaffray & Co (Filed With SEC on August 30, 2019)

Supplemental Agreement to Cooperation Agreement, dated April 10, 2019, by and among Fulgent Genetics, Inc., Shenzhen Fujin Gene Technology Co., Ltd., Xilong Science Co., Ltd. and... (Filed With SEC on August 12, 2019)

Commercial Lease, dated April 1, 2018, by and between 4401 Santa Anita Corporation and Fulgent Genetics, Inc (Filed With SEC on March 22, 2019)

Commercial Lease, dated January 31, 2018, by and between E & E Plaza LLC and Fulgent Therapeutics LLC (Filed With SEC on March 22, 2019)

Amended and Restated Fulgent Genetics, Inc. 2016 Omnibus Incentive Plan (Filed With SEC on May 21, 2018)

Director Compensation Program of the registrant, effective as of September 28, 2016 and amended November 2, 2017 (Filed With SEC on March 20, 2018)

Commercial Lease, dated January 31, 2018, by and between E & E Plaza LLC and Fulgent Therapeutics LLC (Filed With SEC on March 20, 2018)

__________________________________________ Technical Know-how License Agreement __________________________________________ between Fulgent Genetics, Inc. and Fujian Fulgent Gene... (Filed With SEC on August 14, 2017)

Cooperation Agreement on the Establishment of Fujian Fujun Gene Biotech Co., Ltd. among Shenzhen Fujin Gene Science & Technology Co., Ltd. Xilong Scientific Co., Ltd. and Fuzhou... (Filed With SEC on August 14, 2017)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on March 17, 2017)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN (Filed With SEC on September 26, 2016)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN (Filed With SEC on September 19, 2016)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on September 19, 2016)

Signature(s)Guaranteed: Medallion Guarantee Stamp (Filed With SEC on September 19, 2016)

FULGENT GENETICS, INC. DIRECTOR COMPENSATION PROGRAM (Filed With SEC on September 19, 2016)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN OPTION SUBSTITUTION AWARD (Filed With SEC on September 2, 2016)

COMMERCIAL LEASE (Filed With SEC on September 2, 2016)

CONTRIBUTION AND ALLOCATION AGREEMENT (Filed With SEC on September 2, 2016)

SEVERANCE AGREEMENT (Filed With SEC on September 2, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on September 2, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on September 2, 2016)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT SUBSTITUTION AWARD (Filed With SEC on September 2, 2016)

[ l ] Shares Fulgent Genetics, Inc. Common Stock, par value $0.0001 per share UNDERWRITING AGREEMENT (Filed With SEC on September 2, 2016)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on September 2, 2016)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN NOTICE OF STOCK OPTION AWARD (Filed With SEC on September 2, 2016)

FULGENT GENETICS, INC. 2016 OMNIBUS INCENTIVE PLAN (Filed With SEC on September 2, 2016)

FULGENT THERAPEUTICS LLC AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED SHARE UNIT AWARD (Filed With SEC on September 2, 2016)

FULGENT THERAPEUTICS LLC AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN NOTICE OF PROFITS INTEREST GRANT (Filed With SEC on September 2, 2016)

FULGENT THERAPEUTICS LLC AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN NOTICE OF OPTION GRANT (Filed With SEC on September 2, 2016)

FULGENT THERAPEUTICS LLC AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN ADOPTED ON OCTOBER 16, 2015 AMENDED AND RESTATED ON APRIL 4, 2016 AMENDED AND RESTATED ON AUGUST 10, 2016... (Filed With SEC on September 2, 2016)

INDEMNIFICATION AGREEMENT (Filed With SEC on September 2, 2016)

FULGENT THERAPEUTICS LLC INVESTORS RIGHTS AGREEMENT Dated as of May 17, 2016 TABLE OF CONTENTS (Filed With SEC on September 2, 2016)

FORM OF AGREEMENT ANDPLAN OF MERGER (Filed With SEC on September 2, 2016)

Fulgent Genetics, Inc. (57)